Human health is strongly intertwined with the health of the microbiome. A large number of studies have shown that the human ...

When added to chemotherapy, researchers found no significant difference in overall or progression-free survival between PD-1 ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Blood clots form in response to signals from the lungs of cancer patients -- not from other organ sites, as previously thought -- according to a preclinical study. Clots are the second-leading cause ...

Lung cancer screening aims to find lung cancer early. This is when there are more treatment options available and there is the best chance of treating it successfully. In the UK, the National ...

Objectives To investigate the sex-specific association between smoking and lung cancer. Design Systematic review and meta-analysis. Data sources We searched PubMed and EMBASE from 1 January 1999 to 15 ...

Non-small cell cancer (NSCLC) tumor markers are signs of specific types of tumors. Doctors look for these markers to aid in the diagnosis and treatment of lung cancer. Doctors use several tests to ...

Novel therapies targeting molecular pathways, including DLL3 and PARP inhibitors, show promise in improving SCLC survival outcomes. Tarlatamab, a DLL3-targeting bispecific T-cell engager, achieved ...

Lung cancer, one of the four most common types of cancer in the UK, sees over 49,000 new cases each year, according to Cancer Research UK. This disease is triggered by an uncontrolled growth of ...

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80 to 85% of all cases of lung cancer. There are different stages of NSCLC, ranging from 0 to 4; ...

Small cell lung cancer (SCLC) accounts for about 15% of lung cancer cases and is categorized into limited and extensive stages. Treatment options include radiation, chemotherapy, and immunotherapy ...